Browsing: wegovy

MENA Newswire,  NEW YORK: Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available in an oral pill form in the United States, marking a major…

FDA approves Novo Nordisk’s Wegovy pill, the first oral GLP-1 therapy for obesity, offering a new weight loss option for adults with chronic conditions.

Uninsured Americans can now access Ozempic for $499 monthly as Novo Nordisk rolls out a direct-to-consumer model through telehealth providers.

Novo Nordisk shares dropped 20% after cutting full-year guidance and naming a new CEO, citing U.S. market weakness for Wegovy and Ozempic.